FDA Approved: VALTOCO — Supplemental Application (Neurelis, Inc)

View source ↗

Summary

FDA approved a supplemental application for VALTOCO (diazepam nasal spray) from Neurelis, Inc., resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• VALTOCO (diazepam nasal spray)

Snippet

SUPPL AP for VALTOCO (DIAZEPAM)